StoxSymbiotec Pharmalab Limited share price & analysis
NSE: SYMBIOTEC · Unclassified · as of 06 Nov 2026
₹1,513.60+19.04%
Market cap₹9,726 Cr
P/E—
Industry P/E19.1
P/B7.15
ROE—
Debt / equity0.24
Dividend yield—
EPS (TTM)—
52W high₹1,513.60
52W low₹1,003.35
Net margin—
Operating margin—
Returns
1 month+33.3%
6 months—
1 year—
3Y CAGR—
5Y CAGR—
10Y CAGR—
From 52W high+0.0%
Technical indicators
50-day avg—
200-day avg—
RSI (14)69
Avg volume (20D)10,31,277
StoxGud checklist: Bearish setup · 2/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
About Symbiotec Pharmalab Limited stock
Symbiotec Pharmalab Limited (SYMBIOTEC) shares closed at ₹1,513.60 on 06 Nov 2026, up 19.04% on the day. On StoxGud's 10-point checklist it scores 2/10, a bearish setup.
Unclassified peers
| Company | Price | Market cap | P/E | 1Y |
|---|---|---|---|---|
| Avantel Limited | ₹138.69 | ₹36,86,04,549 Cr | — | -22.1% |
| Ducol Organics And Colours Limited | ₹120.00 | ₹19,55,275 Cr | — | -25.9% |
| Jio Platforms Limited | ₹1,406.40 | ₹12,57,181 Cr | — | — |
| SBI Funds Management Limited | ₹499.55 | ₹1,01,750 Cr | — | — |
| Tamilnadu Telecommunication Limited | ₹9.93 | ₹91,314 Cr | — | -21.1% |
| Manipal Health Enterprises Limited | ₹646.70 | ₹76,294 Cr | — | — |
FAQs
What is the share price of Symbiotec Pharmalab Limited?
Symbiotec Pharmalab Limited (SYMBIOTEC) closed at ₹1,513.60 on NSE on 06 Nov 2026.
What is the 52-week high and low of Symbiotec Pharmalab Limited?
The 52-week high is ₹1,513.60 and the 52-week low is ₹1,003.35.
What is the market cap of Symbiotec Pharmalab Limited?
The market capitalisation of Symbiotec Pharmalab Limited is ₹9,726 Cr.